8 | 8 | | 2 |
---|
9 | 9 | | |
---|
10 | 10 | | 3 |
---|
11 | 11 | | LONG TITLE |
---|
12 | 12 | | 4 |
---|
13 | 13 | | General Description: |
---|
14 | 14 | | 5 |
---|
15 | 15 | | This bill addresses provisions related to water fluoridation and prescription fluoride |
---|
16 | 16 | | 6 |
---|
17 | 17 | | supplements. |
---|
18 | 18 | | 7 |
---|
19 | 19 | | Highlighted Provisions: |
---|
20 | 20 | | 8 |
---|
21 | 21 | | This bill: |
---|
22 | 22 | | 9 |
---|
23 | 23 | | ▸ defines terms; |
---|
24 | 24 | | 10 |
---|
25 | 25 | | ▸ prohibits adding fluoride to public water systems; |
---|
26 | 26 | | 11 |
---|
27 | 27 | | ▸ allows a pharmacist to prescribe fluoride; and |
---|
28 | 28 | | 12 |
---|
29 | 29 | | ▸ directs the Division of Professional Licensing to establish guidelines for prescribing |
---|
30 | 30 | | 13 |
---|
31 | 31 | | fluoride. |
---|
32 | 32 | | 14 |
---|
33 | 33 | | Money Appropriated in this Bill: |
---|
34 | 34 | | 15 |
---|
35 | 35 | | None |
---|
36 | 36 | | 16 |
---|
37 | 37 | | Other Special Clauses: |
---|
38 | 38 | | 17 |
---|
39 | 39 | | None |
---|
40 | 40 | | 18 |
---|
41 | 41 | | Utah Code Sections Affected: |
---|
42 | 42 | | 19 |
---|
43 | 43 | | AMENDS: |
---|
44 | 44 | | 20 |
---|
45 | 45 | | 58-17b-627, as last amended by Laws of Utah 2022, Chapter 255 |
---|
46 | 46 | | 21 |
---|
47 | 47 | | REPEALS AND REENACTS: |
---|
48 | 48 | | 22 |
---|
49 | 49 | | 19-4-111, as last amended by Laws of Utah 2023, Chapter 16 |
---|
50 | 50 | | 23 |
---|
51 | 51 | | REPEALS: |
---|
52 | 52 | | 24 |
---|
53 | 53 | | 19-4-111.1, as last amended by Laws of Utah 2013, Chapter 321 |
---|
54 | 54 | | 25 |
---|
55 | 55 | | 19-4-111.2, as last amended by Laws of Utah 2013, Chapter 321 |
---|
56 | 56 | | 26 |
---|
57 | 57 | | |
---|
58 | 58 | | 27 |
---|
66 | 66 | | 31 |
---|
67 | 67 | | fluoride ion and is used to fluoridate drinking water, including: |
---|
68 | 68 | | 32 |
---|
69 | 69 | | (a) fluorosilicic acid; |
---|
70 | 70 | | 33 |
---|
71 | 71 | | (b) sodium fluorosilicate; or |
---|
72 | 72 | | 34 |
---|
73 | 73 | | (c) sodium fluoride. |
---|
74 | 74 | | 35 |
---|
75 | 75 | | (2) A person may not add fluoride to water in, or water that will be introduced into, a public |
---|
76 | 76 | | 36 |
---|
77 | 77 | | water system. |
---|
78 | 78 | | 37 |
---|
79 | 79 | | (3) A political subdivision may not enact or enforce an ordinance that requires or permits |
---|
80 | 80 | | 38 |
---|
81 | 81 | | the addition of fluoride to water in, or water that will be introduced into, a public water |
---|
82 | 82 | | 39 |
---|
83 | 83 | | system. |
---|
84 | 84 | | 40 |
---|
85 | 85 | | Section 2. Section 58-17b-627 is amended to read: |
---|
86 | 86 | | 41 |
---|
87 | 87 | | 58-17b-627 . Prescription of drugs or devices by a pharmacist. |
---|
88 | 88 | | 42 |
---|
89 | 89 | | (1) Beginning January 1, 2022, a pharmacist may prescribe a prescription drug or device if: |
---|
90 | 90 | | 43 |
---|
91 | 91 | | (a) prescribing the prescription drug or device is within the scope of the pharmacist's |
---|
92 | 92 | | 44 |
---|
93 | 93 | | training and experience; |
---|
94 | 94 | | 45 |
---|
95 | 95 | | (b) the prescription drug or device is designated by the division by rule under Subsection |
---|
96 | 96 | | 46 |
---|
97 | 97 | | (3)(a); and |
---|
98 | 98 | | 47 |
---|
99 | 99 | | (c) the prescription drug or device is not a controlled substance that is included in |
---|
100 | 100 | | 48 |
---|
101 | 101 | | Schedules I, II, III, or IV of: |
---|
102 | 102 | | 49 |
---|
103 | 103 | | (i) Section 58-37-4; or |
---|
104 | 104 | | 50 |
---|
105 | 105 | | (ii) the federal Controlled Substances Act, Title II, P.L. 91-513. |
---|
106 | 106 | | 51 |
---|
107 | 107 | | (2) Nothing in this section requires a pharmacist to issue a prescription for a prescription |
---|
108 | 108 | | 52 |
---|
109 | 109 | | drug or device. |
---|
110 | 110 | | 53 |
---|
111 | 111 | | (3) The division shall make rules in accordance with Title 63G, Chapter 3, Utah |
---|
112 | 112 | | 54 |
---|
113 | 113 | | Administrative Rulemaking Act, to: |
---|
114 | 114 | | 55 |
---|
115 | 115 | | (a) designate the prescription drugs or devices that may be prescribed by a pharmacist |
---|
116 | 116 | | 56 |
---|
117 | 117 | | under this section, beginning with prescription drugs or devices that address a public |
---|
118 | 118 | | 57 |
---|
119 | 119 | | health concern that is designated by the Department of Health and Human Services, |
---|
120 | 120 | | 58 |
---|
121 | 121 | | including: |
---|
122 | 122 | | 59 |
---|
123 | 123 | | (i) post-exposure HIV prophylaxis; |
---|
124 | 124 | | 60 |
---|
125 | 125 | | (ii) pre-exposure HIV prophylaxis; |
---|
126 | 126 | | 61 |
---|
127 | 127 | | (iii) self-administered hormonal contraceptives; |
---|
135 | 135 | | 65 |
---|
136 | 136 | | (b) create guidelines that a pharmacist must follow when prescribing a prescription drug |
---|
137 | 137 | | 66 |
---|
138 | 138 | | or device, including guidelines: |
---|
139 | 139 | | 67 |
---|
140 | 140 | | (i) for notifying the patient's primary care or other health care provider about the |
---|
141 | 141 | | 68 |
---|
142 | 142 | | prescription; and |
---|
143 | 143 | | 69 |
---|
144 | 144 | | (ii) to prevent the over-prescription of drugs or devices including but not limited to |
---|
145 | 145 | | 70 |
---|
146 | 146 | | antibiotics; |
---|
147 | 147 | | 71 |
---|
148 | 148 | | (c) address when a pharmacist should refer the patient to an appropriate health care |
---|
149 | 149 | | 72 |
---|
150 | 150 | | provider or otherwise encourage the patient to seek further medical care; and |
---|
151 | 151 | | 73 |
---|
152 | 152 | | (d) implement the provisions of this section. |
---|
153 | 153 | | 74 |
---|
154 | 154 | | (4) The division shall make rules under Subsection (3) in collaboration with: |
---|
155 | 155 | | 75 |
---|
156 | 156 | | (a) individuals representing pharmacies and pharmacists; |
---|
157 | 157 | | 76 |
---|
158 | 158 | | (b) individuals representing physicians and advanced practice clinicians; and |
---|
159 | 159 | | 77 |
---|
160 | 160 | | (c)(i) if the executive director of the Department of Health and Human Services is a |
---|
161 | 161 | | 78 |
---|
162 | 162 | | physician, the executive director of the Department of Health and Human Services; |
---|
163 | 163 | | 79 |
---|
164 | 164 | | (ii) if the executive director of the Department of Health and Human Services is not a |
---|
165 | 165 | | 80 |
---|
166 | 166 | | physician, a deputy director who is a physician in accordance with Subsection |
---|
167 | 167 | | 81 |
---|
168 | 168 | | 26B-1-203(4); or |
---|
169 | 169 | | 82 |
---|
170 | 170 | | (iii) a designee of the individual described in Section 26B-1-203. |
---|
171 | 171 | | 83 |
---|
172 | 172 | | (5) Before November 1 of each year, the division, in consultation with the individuals |
---|
173 | 173 | | 84 |
---|
174 | 174 | | described in Subsection (4), shall: |
---|
175 | 175 | | 85 |
---|
176 | 176 | | (a) develop recommendations for statutory changes to improve patient access to |
---|
177 | 177 | | 86 |
---|
178 | 178 | | prescribed drugs in the state; and |
---|
179 | 179 | | 87 |
---|
180 | 180 | | (b) report the recommendations developed under Subsection (5)(a) to the Health and |
---|
181 | 181 | | 88 |
---|
182 | 182 | | Human Services Interim Committee. |
---|
183 | 183 | | 89 |
---|
184 | 184 | | Section 3. Repealer. |
---|
185 | 185 | | 90 |
---|
186 | 186 | | This bill repeals: |
---|
187 | 187 | | 91 |
---|
188 | 188 | | Section 19-4-111.1, Provision of fluoridated water -- Request of resident. |
---|
189 | 189 | | 92 |
---|
190 | 190 | | Section 19-4-111.2, Provision of fluoridated water -- Emergency circumstances. |
---|
191 | 191 | | 93 |
---|
192 | 192 | | Section 4. Effective Date. |
---|
193 | 193 | | 94 |
---|
194 | 194 | | This bill takes effect on May 7, 2025. |
---|
195 | 195 | | - 3 - |
---|